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Vision-targeted health related quality of life
in older adults: patient-reported visibility
problems in low luminance activities are
more likely to decline than daytime
activities
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Abstract
Background: Commonly used vision-targeted health-related quality of life questionnaires almost exclusively
focus items on vision under daytime conditions. Older adults even when in good eye health frequently report
experiencing vision problems at night and under low environmental light levels, and psychophysical studies also
document these visibility problems. Here we compare the progression of self-reported low luminance visibility
problems and self-reported visibility problems under daytime conditions in older adults.
Methods: Trained interviewers administered two questionnaires to older adults in normal eye health: the National
Eye Institute Visual Function Questionnaire – 25 (NEI VFQ-25) where items are almost entirely focused on difficulties
in daytime activities, and the Low Luminance Questionnaire (LLQ) where items are focused on difficulties seeing at
night and under low luminance conditions. The following visual functions were also measured: visual acuity, low
luminance visual acuity, low luminance deficit, contrast sensitivity, light sensitivity in the macula, and rod-mediated
dark adaptation. The protocol was repeated 3 years later.
Results: Scores on the NEI VFQ-25 composite and its subscales were unchanged between baseline and 3-year
follow-up, whereas scores on the LLQ composite and 5 of 6 subscales significantly decreased (corresponding to less
functionality) at the 3-year follow-up. Participants were more likely to display a ≥ 5 point decrease on the LLQ
composite than on the NEI VFQ-25 over 3 years. Visual functional tests were largely unrelated to changes in NEI
VFQ-25 and LLQ scores from baseline to follow-up.
Conclusions: Older adults’ vision-targeted quality of life as measured by questionnaire is more likely to exhibit a
practically significant decrease over 3 years using a questionnaire that focused on low luminance activities (LLQ)
than one focused on daytime activities (NEI VFQ-25). That the results of visual functional testing did not correspond
to older adults’ decline in self-reported problems in low luminance activities emphasizes the importance of
questionnaires in understanding visual difficulties from the patients’ own perspective.
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Background
Older adults experience aging-related challenges in the
visual activities of daily living, even in the absence of the
common eye conditions and diseases of later adulthood
(e.g., cataract, age-related macular degeneration (AMD),
glaucoma, diabetic retinopathy). They frequently report
experiencing vision problems at night and under low en-
vironmental light levels. For example, they cite difficulty
with night driving and often avoid it [1–3] and report
task difficulties under low illumination (e.g., reading a
menu in a dimly lit restaurant) [4]. Psychophysical studies
confirm that older adults, even when free of significant
ocular conditions, tend to exhibit decreased scotopic and
mesopic light sensitivity, contrast sensitivity, and acuity, as
compared to younger adults [5–10].
It is thus concerning that commonly used vision-
targeted health-related quality of life questionnaire instru-
ments designed for use in the older adult population
almost exclusively focus items on vision under photopic
(day-time) conditions, such as the National Eye Institute
Visual Function Questionnaire (NEI VFQ-25,) [11] among
others [12, 13]. Thus, these questionnaire instruments do
not adequately address one of the major vision problem
areas cited by older adults, activities at lower ambient light
levels. In response to a need for a questionnaire focused
on low luminance content, a questionnaire was recently
developed specifically targeted at this content; the Low
Luminance Questionnaire (LLQ) is a 32-item question-
naire designed for use with older adults and has established
content and construct validity and test-retest reliability
[14, 15] The LLQ is accessible at http://www.uab.edu/
medicine/ophthalmology/images/Research/Low%20Lu
minance.pdf ). It has six subscales: driving, extreme
lighting, mobility, emotional distress, general dim lighting,
peripheral vision.
Even though considerable research has shown that
older adults’ vision problems are exacerbated under low
luminance as measured psychophysically and by self-
report, it remains to be determined whether self-reported
low luminance visibility problems progress more rapidly
over time in older adults as they age as compared to visi-
bility issues they cite under daytime conditions. Here we
examine whether responses on the LLQ display larger
decreases over 3 years in older adults free of significant
ocular conditions, as compared to responses on the NEI
VFQ-25, which is largely focused on daytime activ-
ities. We also examined whether decreases in ques-
tionnaire scores were related to visual function at
baseline and change in visual function over a 3-year
period of follow-up.
Method
The protocol (#F080205001) was approved by the Insti-
tutional Review Board of the University of Alabama at
Birmingham (UAB) and followed the tenants of the
Declaration of Helsinki. Informed consent was obtained
from all participants after the nature and purpose of the
study was described. This study made use of the sample
assembled for the Alabama Study on Early Age-Related
Macular Degeneration (ALSTAR), a prospective study of
older adults in normal macular health at baseline [16, 17].
As described previously, participants were recruited from
two primary care ophthalmology practices in the Callahan
Eye Hospital at UAB. Eligibility criteria were as follows:
(1) age ≥ 60 years old; (2) normal macular health in both
eyes as determined by 3-field digital stereo-fundus photos
(Carl Zeiss Meditec 450 Plus camera, Dublin, CA) evalu-
ated by an experienced grader masked to other study
variables. Each eye’s grade had to be 1 in the Age-Related
Eye Disease Study (AREDS) 9-step classification system
[18], indicating normal macular health. (3) No previous
diagnoses of glaucoma, other retinal conditions, optic
nerve conditions, corneal disease, diabetes, Alzheimer’s
disease, Parkinson’s disease, brain injury, other neuro-
logical or psychiatric conditions as revealed by the medical
record or by self-report.
A baseline visit consisted of the following. Participants
provided information on demographic characteristics (age,
gender, race/ethnicity). The NEI VFQ-25 and the LLQ
were interviewer administered. Both of these instruments
were developed using classical test theory, [19] and we
elected to score each instrument using recommended
scoring instructions by their developers [11, 14] The NEI
VFQ-25 and the LLQ composite and subscale scores are
computed using the same method, that is, by scaling indi-
vidual item responses from 0 to 100, where 100 represents
the highest functional level and 0 the lowest, and then
averaging the individual items. Other options for scoring
these types of questionnaires include a collection of
measurement models referred to as item response theory
[19]. General cognitive status was estimated by the Mini-
Mental State Examination (MMSE) [20]; scores less than
24 indicated cognitive impairment.
Several visual function tests were also administered;
tests were administered for each eye unless otherwise
noted. The eye with better visual function was used in
analyses. Best-corrected visual acuity for each eye was
assessed via the Electronic Visual Acuity tester [21]
(EVA; JAEB Center, Tampa FL) under photopic condi-
tions (100 cd/m2) and expressed as the logarithm of the
minimum angle resolvable (logMAR). The EVA was also
used to assess low luminance visual acuity for each eye,
with participants viewing letters through a 1.5 log unit
neutral density filter [22]. The filter reduced background
luminance to 3.1 cd/m2. To determine how much log-
MAR decreased under conditions of the lower light level
as compared to the photopic (100 cd/m2) assessment, we
defined a decrease in visual acuity under low luminance
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by the increase in logMAR (referred to as the “low lumi-
nance deficit” [22]). Contrast sensitivity for each eye was
estimated by the Pelli-Robson chart [23] (Precision Vision,
La Salle, IL) with mean luminance of 100 cd/m2, the
letter-by-letter scoring method [24], and expressed as
logarithm of sensitivity. Macular light sensitivity for each
eye was assessed using the Humphrey Field Analyzer (Carl
Zeiss Meditec, Dublin, CA) and the 24-2 SITA standard
protocol, as previously described [25]. Sensitivities for 16
test targets within a 9° × 9° macular region were averaged,
and expressed as decibels (dB). Rod-mediated dark adap-
tation was measured using a computerized dark adapt-
ometer as described previously [16, 17]. Test targets with
a diameter of 2° were positioned at 5° on the inferior verti-
cal meridian (superior to the fovea on the retina). Follow-
ing a photobleach exposure (equivalent ~83 % bleach),
sensitivity was measured at 30-s intervals for 20 min
following bleach offset. Dark adaptation time was defined
by the rod intercept, the time in minutes needed by the
participant to reach a criterion sensitivity value in the
latter half of the second component of rod recovery. Due
to time constraints in the protocol visit, dark adaptation
was measured in one eye only.
Administration of the NEI VFQ-25, LLQ, and visual
function testing was repeated 3 years after the baseline
visit. The only exception was measurement of macular
light sensitivity, which was not repeated at the 3-year
follow-up due to time constraints in the study protocol.
The eye with better visual function was used in analyses.
Baseline and 3-year follow-up NEI-VFQ and LLQ
composite and subscale scores were compared using
paired t-tests. Unpaired t-tests were used to compare
participants whose LLQ composite did and did not
decrease by five or more points with respect to visual
function variables. A similar analysis was conducted for
the NEI-VFQ composite. P-values less than 0.05 (two-
tailed) were considered statistically significant.
Results
There were 365 participants in the ALSTAR study in
normal eye health who completed both the baseline and
follow-up LLQ and NEI VFQ-25. The vast majority of
the sample were in their 60s or 70s (97.5 %) and were
white of non-Hispanic origin (94.5 %) (Table 1). Ap-
proximately 2/3 of the sample was women. In terms of
cognitive status, 98.1 % (358 of 365) had MMSE scores
in the non-cognitively impaired range (24–30).
Table 2 shows the mean and standard deviation for
the NEI VFQ-25 composite and subscale scores at both
baseline and the 3-year follow-up, along with the corre-
sponding change in score (baseline minus follow-up
score). The NEI VFQ-25 composite and all subscales
were unchanged between baseline and 3-year follow-up
(except for ocular pain which increased slightly). Table 3
provides the analogous information for the LLQ. The
LLQ composite and 5 of 6 LLQ subscales decreased
between baseline and 3 years later (all p < 0.007). The
exception was the general dim lighting subscale (p =
0.0579), which did not reach statistical significance.
Although the scores for the LLQ composite and 5 sub-
scales decreased over 3 years, the decrease on average
was small, approximately 1 to 3 points, leading one to
question its clinical or practical significance. Thus we
defined a clinically significant decrease in LLQ score to
be a decrease of ≥ 5 points from baseline to 3-year follow
up. Our rationale was based on an accepted approach to
determining minimally important changes in health-
related quality of life, namely defining it as approximately
half a standard deviation [26]. The standard deviation for
the LLQ composite was approximately 10, and thus we
defined our minimally important difference as 5 points on
the LLQ. Eighty-five of 365 (23.3 %) participants had ≥ 5
point decrease in the LLQ composite between baseline
and follow-up (Table 4), which is significantly larger than
the 41 participants (11.2 %) who had ≥ 5 point decrease on
the NEI VFQ-25 composite over the same time period,
p < 0.0001. The seven individuals with MMSE scores < 24
(indicating cognitive impairment) had greater decreases
on both the NEI VFQ-25 and LLQ at the 3-year follow-
up, as compared to those with MMSE scores ≥ 24,
although this association did not reach statistical signifi-
cance for the LLQ (p = 0.0024 and p = 0.0801, respect-
ively). The pattern of results in the tables did not
change when these seven persons were dropped from
the analysis.
Table 1 Demographic and cognitive status characteristics of
the sample, N = 365
Characteristic n (%)








White, non-Hispanic 345 (94.5)
African American 16 (4.4)
Other 4 (1.1)




≤ 23 7 (1.9)
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We examined whether visual function (visual acuity,
contrast sensitivity, macular light sensitivity, low lumi-
nance deficit, rod-mediated dark adaptation) at baseline
and change in these visual functions from baseline to
follow-up were associated with participants who had ≥ 5
point decrease in LLQ composite score at 3 years (Table 5).
No aspect of visual function tested at baseline or its
change score was related to those who had ≥ 5 point LLQ
composite drops. This was also the case for the NEI VFQ-
25 with one exception; a 0.10 logMAR decline in visual
acuity was associated with a ≥ 5-point decrease on the
NEI VFQ-25, as compared to those who declined < 5
points.
Discussion
Our results suggest that a vision-targeted health-related
quality of life questionnaire whose content is focused on
night-time and low luminance visual activities is more
likely to show a decline over time in older adults than a
questionnaire that focuses on daytime activities. Older
adults’ composite scores were more likely to have a prac-
tically significant decrease over 3 years using a question-
naire that focused on low luminance activities (LLQ)
than one focused on daytime activities (NEI VFQ-25). In
addition, scores on five of six subscales of the LLQ sig-
nificantly declined 3 years later, however none of the
twelve subscales of NEI VFQ-25 declined over the same
Table 2 NEI-VFQ Composite and Subscales scores at baseline and follow-up for participants in normal macular health group and
the change in scores over this 3-year period (N = 365)
Normal macular health at baseline a
NEI-VFQ subscales Baseline score 3-year follow-up score Difference a P-value
M (SD)
Composite 93.9 (5.5) 93.9 (5.9) 0.0 0.9875
General health 73.9 (21.7) 72.8 (21.7) 1.1 0.2724
General vision 83.7 (11.2) 82.5 (11.7) 1.2 0.0781
Near vision 92.3 (11.1) 92.7 (11.4) −0.5 0.4984
Distance vision 93.0 (8.9) 92.8 (10.0) 0.2 0.6675
Driving 89.7 (10.9) 90.1 (10.6) −0.3 0.5635
Peripheral vision 94.9 (11.9) 94.7 (12.5) 0.3 0.6773
Color vision 97.9 (8.85 98.4 (7.4) −0.3 0.3699
Ocular Pain 90.3 (12.0) 91.8 (11.7) −1.4 0.0221
Vision-specific
Role difficulties 96.0 (9.8) 95.7 (10.6) 0.3 0.6139
Dependency 99.4 (3.5) 99.0 (5.0) 0.4 0.1419
Social functioning 98.7 (5.0) 99.1 (4.5) −0.3 0.3565
Mental health 94.5 (8.1) 94.0 (10.5) 0.5 0.3654
a Difference is baseline score minus follow-up score
Table 3 LLQ Composite and Subscales scores at baseline and follow-up for participants in normal macular health group and the
change in scores over this 3-year period (N = 365)
Normal macular health at baseline a
LLQ subscales Baseline score 3-year follow-up score Difference a P-value
M (SD)
Composite 91.4 (8.8) 89.7 (10.3) 1.7 <0.0001
Driving 85.0 (19.0) 81.8 (22.8) 3.1 0.0009
Extreme lighting conditions 87.2 (11.2) 85.0 (13.5) 2.2 0.0005
Mobility 96.0 (7.5) 94.6 (8.9) 1.4 0.0014
Emotional distress 97.6 (6.2) 96.3 (7.9) 1.2 0.0023
General dim-lighting 91.5 (11.4) 90.5 (11.8) 1.0 0.0579
Peripheral vision 93.4 (12.3) 91.4 (14.8) 2.0 0.0065
a Difference is baseline score minus follow-up score
Owsley and McGwin BMC Ophthalmology  (2016) 16:92 Page 4 of 6
period. Our results imply that the use of questionnaires
in clinical vision research on older adults that exclusively
target daytime visual activities are likely to miss certain
types and the extent of visibility problems older adults
experience in daily life. It is noteworthy that this pattern
of results emerged even in older adults in normal eye
health, free of the common eye conditions of aging.
Common ageing-related eye conditions such as AMD
and glaucoma are associated with visual deficits under
mesopic and scotopic conditions, which are more severe
than what would be expected through aging alone
[14, 27–29]. It remains to be determined whether
changes in the LLQ are associated with patients’ percep-
tions about the worsening of low luminance vision in
these conditions, as they progress.
This greater tendency for older adults’ self-report
activity problems under low luminance than in photopic
conditions is consistent with psychophysical reports that
older adults’ visibility problems are accentuated under
mesopic and scotopic conditions, as compared to youn-
ger adults [7–9, 30]. However, in this study there was no
association between psychophysically measured deficits
and self-reported deficits as reported on the LLQ.
Those persons who had worse visual function at base-
line or had more visual decrease over 3 years, were
not more likely to be those who had larger decreases
on the LLQ over the 3 year period. This study fo-
cused on older adults in normal health, and it is pos-
sible that psychophysical testing is not sensitive
enough to quantitate the low luminance difficulties in
everyday life older adults in good eye health experience
subjectively.
Conclusions
How patients view their own visual task difficulties and
the emotional consequences these challenges present is
an appropriate part of understanding the impact of eye
conditions and aging on everyday life. Patient reported
outcomes, such as questionnaires on vision-targeted
health-related quality of life, are an essential part of
evaluating the impact of ophthalmic interventions to
slow the progression of age-related eye conditions such
as AMD, glaucoma, and diabetic retinopathy. Yet also
part of understanding the role of patient reported out-
comes is the transition of aging-associated conditions
from normal eye health to their earliest incident emer-
gence. Thus, it is important to recognize, that even in
Table 4 Percentage of participants having a ≥ 5 point decrease





decrease by≥ 5 points
p-value
n (%)
NEI VFQ-25 41 (11.2) 324 (88.8) <0.0001
LLQ 85 (23.3) 280 (76.7)
Table 5 Vision variables stratified by participants with a ≥ 5 point decrease in the LLQ composite from baseline to 3-year follow-up




LLQ composite did not
decrease by≥ 5 points
N = 280
p-value NEI VFQ-25 composite
decreased by≥ 5 points
N =
NEI VFQ-25 composite did
not decrease by ≥ 5 points
N =
p-value
Mean (standard deviation) unless otherwise noted
Visual acuity at baseline
(logMAR)
−0.02 −0.02 0.9908 0.00 −0.02 0.1196
Change in visual acuty a −0.06 −0.04 0.4341 −0.10 −0.04 0.0145
Contrast sensitivity, log
sensitivity
1.63 1.65 0.1482 1.65 1.64 0.7051
Change in contrast
sensitivity
0.05 0.04 0.7315 0.06 0.04 0.3192
Light sensitivity, dB b 30.4 30.6 0.3264 30.5 30.6 0.8041
Low luminance deficit 0.30 0.29 0.5884 0.31 0.29 0.2780
Change in low
luminance deficit




10.45 10.10 0.4050 10.1 10.2 0.8394
Change in rod-mediated
dark adaptation
−1.26 −0.85 0.3121 −1.8 −0.8 0.0832
a Change in visual function variables defined as the value at baseline minus the value at the 3-year follow-up
b Light sensitivity was only measured at baseline
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aging, low luminance activities already play a significant
role in reducing vision-targeted health related quality of
life, and a health-related quality of life questionnaire
reflects this trend.
Abbreviations
AMD, age-related macular degeneration; ALSTAR, Alabama Study on Early
Age-Related Macular Degeneration; AREDS, Age-Related Eye Disease Study;
dB, decibels; LLQ, Low Luminance Questionnaire; logMAR, logarithm of the
minimum angle of resolution; MMSE,, Mini-mental State Examination; NEI
VFQ-25, National Eye Institute Visual Functioning Questionnaire (25-item version);




This research was supported by grants from the National Institute on Aging
(R01AG04212), Research to Prevent Blindness, and the EyeSight Foundation
of Alabama.
Availability of data and materials
The data have not yet been placed in a publicly available repository since
the investigators are still in the process of analyzing and publishing the
ALSTAR study findings.
Authors’ contributions
CO designed the study, oversaw data collection, interpreted the data, and
drafted the manuscript. GMGJ designed the study, designed the statistical
analyses of the data, interpreted the data, and drafted the manuscript.
Both authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
No personal data or clinical data associated with personal data are presented
in this manuscript.
Ethics approval and consent to participate
The protocol (#F080205001) was approved by the Institutional Review Board
of the University of Alabama at Birmingham (UAB) and followed the tenants
of the Declaration of Helsinki. Informed consent was obtained from all
participants after the nature and purpose of the study was described.
Author details
1Department of Ophthalmology, School of Medicine, University of Alabama
at Birmingham, Birmingham, AL 35294-0009, USA. 2Department of
Epidemiology, School of Public Health, University of Alabama at Birmingham,
Birmingham, AL 35294-0022, USA.
Received: 26 January 2016 Accepted: 23 June 2016
References
1. Ball K, Owsley C, Stalvey B, Roenker DL, Sloane M, Graves M. Driving
avoidance and functional impairment in older drivers. Accid Anal Prev.
1998;30:313–22.
2. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD, National Eye
Institute Visual Function Questionnaire Field Test Investigators. Psychometric
properties of the National Eye Institute visual function questionnaire
(NEI-VFQ). Arch Ophthalmol. 1998;116:1496–504.
3. Betz ME, Carpenter CR, Genco E, Carr DB. Driving self restriction and age: a
study of emergency department patients. Inj Epidemiol. 2014;1:18.
4. Kosnik W, Winslow L, Kline D, Rasinski K, Sekuler R. Visual changes in daily
life throughout adulthood. J Gerontol B Psychol Sci Soc Sci. 1988;43:P63–70.
5. Jackson GR, Owsley C, Cordle EP, Finley CD. Aging and scotopic sensitivity.
Vision Res. 1998;38:3655–62.
6. Jackson GR, Owsley C, McGwin GJ. Aging and dark adaptation. Vision Res.
1999;39:3975–82.
7. Sloane ME, Owsley C, Alvarez SL. Aging, senile miosis and spatial contrast
sensitivity at low luminance. Vision Res. 1988;28:1235–46.
8. Sturr JF, Kline GE, Taub HA. Performance of young and older drivers on a
static acuity test under photopic and mesopic luminance conditions. Hum
Factors. 1990;32:1–8.
9. Haegerstrom-Portnoy G, Schneck ME, Brabyn JA. Seeing into old age: vision
function beyond acuity. Optom Vis Sci. 1999;76:141–58.
10. Richards OW. Effects of luminance and contrast on visual acuity, ages 16 to
90 years. Am J Optom Physiol Opt. 1977;54:178–84.
11. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD, NEI VFQ
Field Test Investigators. Development of the 25-item National Eye Institute
Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050–8.
12. Mangione CM, Phillips RS, Seddon JM, Lawrence MG, Cook EF, Dailey R,
Goldman L. Development of the activities of daily vision scale: A measure of
visual functional status. Med Care. 1992;30:1111–26.
13. Steinberg EP, Tielsch JM, Schein OD, Javitt JC, Sharkey P, Cassard SD,
Legro MW, Diener-West M, Bass EB, Damiano AM, et al. The VF-14: an index
of functional impairment in patients with cataract. Arch Ophthalmol. 1994;
112:630–8.
14. Owsley C, McGwin Jr G, Scilley K, Kallies K. Development of a questionnaire
to assess vision problems under low luminance in age-related maculopathy.
Invest Ophthalmol Vis Sci. 2006;47:528–35.
15. Finger RP, Fenwick E, Owsley C, Holz FG, Lamoureux EL. Visual functioning
and quality of life under low luminance: evaluation of the German Low
Luminance Questionnaire. Invest Ophthalmol Vis Sci. 2011;52:8241–9.
16. Owsley C, Huisingh C, Jackson GR, Curcio CA, Szalai AJ, Dashti N, Clark M,
Rookard K, McCrory MA, Wright TT, et al. Associations between abnormal
rod-mediated dark adaptation and health and functioning in older adults
with normal macular health. Invest Ophthalmol Vis Sci. 2014;55:4776–89.
17. Owsley C, McGwin Jr G, Clark ME, Jackson GR, Callahan MA, Kline LB,
Witherspoon CD, Curcio CA. Delayed rod-mediated dark adaptation is a
functional biomarker for incident early age-related macular degeneration.
Ophthalmology. 2016;123:344–51.
18. Age-Related Eye Disease Study Research Group. The Age-Related Eye
Disease Study severity scale for age-related macular degeneration. AREDS
Report No. 17. Arch Ophthalmol. 2005;123:1484–98.
19. Cappelleri JC, Lundy JJ, Hays RD. Overview of classical test theory and item
response theory for the quantitative assessment of items in developing
patient-reported outcomes measures. Clin Ther. 2014;36:648–62.
20. Folstein MF, Folstein SW, McHugh PR. "Mini-mental state": a practical
method for grading the cognitive state of patients for the clinician.
J Psychiatr Res. 1975;12:189–98.
21. Beck RW, Moke PS, Turpin AH, Ferris FLI, SanGiovanni JP, Johnson CA,
Chandler DL, Cox TA, Blair RC, Kraker RT. A computerized method of visual
acuity testing: adaptation of the early treatment of diabetic retinopathy
study testing protocol. Am J Ophthalmol. 2003;135:194–205.
22. Sunness JS, Rubin GS, Applegate CA, Bressler NM, Marsh MJ, Hawkins BS,
Haselwood D. Visual function abnormalities and prognosis in eyes with
age-related geographic atrophy of the macula and good visual acuity.
Ophthalmology. 1997;104:1677–91.
23. Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for
measuring contrast sensitivity. Clin Vis Sci. 1988;2:187–99.
24. Elliott DB, Bullimore MA, Bailey IL. Improving the reliability of the
Pelli-Robson contrast sensitivity test. Clin Vis Sci. 1991;6:471–5.
25. Owsley C, Huisingh C, Clark ME, Jackson GR, McGwin GJ. Comparison of
visual function in older eyes in the earliest stages of age-related macular
degeneration to those in normal macular health. Curr Eye Res h.
2016;41:266–72.
26. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in
health-related quality of life: the remarkable universality of half a standard
deviation. Med Care. 2003;41:582–92.
27. Drum B, Armaly MF, Huppert W. Scotopic sensitivity loss in glaucoma.
Arch Ophthalmol. 1986;104:712–7.
28. Glovinsky Y, Quigley HA, Drum B, Bissett RA, Jampel HD. A whole-field
scotopic retinal sensitivity test for the detection of early glaucoma damage.
Arch Ophthalmol. 1992;110:486–90.
29. Wu Z, Guymer RH, Finger RP. Low luminance deficit and night vision
symptoms in intermediate age-related macular degeneraiton. Br J
Ophthalmol. 2015;100:395–8.
30. Jackson GR, Owsley C. Scotopic sensitivity during adulthood. Vision Res.
2000;40:2467–73.
Owsley and McGwin BMC Ophthalmology  (2016) 16:92 Page 6 of 6
